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A fatal case of enterovirus 71 infection with pulmonary 
edema and rhombencephalitis occurred in Brest, France, in 
April 2007. The virus was identiﬁ  ed as subgenogroup C2. 
This highly neurotropic enterovirus merits speciﬁ  c surveil-
lance outside the Asia-Paciﬁ  c region.
E
nterovirus 71 (EV71), like other enteroviruses (fam-
ily Picornaviridae), induces mostly asymptomatic or 
clinically benign infections. The virus is a leading cause of 
foot and mouth disease and, above all, is an emerging agent 
of acute central nervous system disease (aseptic meningitis, 
ﬂ  accid paralysis, encephalitis). Since its identiﬁ  cation in 
1969, EV71 has been the subject of several studies, particu-
larly over the past decade in the Asia-Paciﬁ  c region where 
several outbreaks have been reported (1–5). Epidemics have 
also been described in the United States, Brazil, and Europe 
(Sweden in 1974, Bulgaria in 1975, and Hungary in 1978) 
(6). EV71 can be divided into 3 independent genogroups 
by molecular typing: A, B, and C (1). Genogroups B and C 
can be further subdivided into subgenogroups B1–B5 and 
C1–C5 (6). Subgenogroups can replace each other within a 
short period of time, but several genotypes can also cocir-
culate as seen in Malaysia (2).
Death caused by this virus occurs rarely; young chil-
dren are especially at risk. This report describes a fatal case 
of acute pulmonary edema with rhombencephalitis that oc-
curred within the course of an EV71 infection in France.
The Case-Patient
In April 2007, a 17-month-old boy was referred to the 
pediatric emergency ward of the Brest University Hospital. 
He had hyperthermia, which had begun 48 hours earlier. 
Upon arrival, he appeared to be in good general condition, 
despite mild respiratory discomfort and episodes of vom-
iting. Nasopharyngitis was diagnosed. He was discharged 
with treatment consisting of symptomatic medication and 
oral rehydration.
He was readmitted to the pediatric emergency unit 
12 hours later, in severe respiratory distress. Disorders 
of consciousness and drowsiness were observed. He was 
immediately given supportive intravenous corticotherapy 
in association with aerosol and oxygen therapy. He was 
subsequently transferred to the pediatric intensive care 
unit. Results of his chest radiograph were normal. Labora-
tory test results were as follows: leukocytosis 23,300/mm3 
(67.5% polynuclear neutrophils), platelets 453,000/mm3, 
hemoglobin 116 g/L, and hematocrit 34.9%. The C-reac-
tive protein value was elevated (11 mg/L) and liver func-
tion was conserved. Severe dyspnea, hyperglycemia (2.02 
g/L), and a decreased blood pressure (38 mm Hg) rapidly 
developed. After the onset of this acute respiratory distress 
syndrome, a second chest radiograph showed marked lung 
inﬁ  ltration. The patient was intubated because of increased 
oxygen dependence. Cardiorespiratory arrest occurred dur-
ing the induction of anesthesia. Despite cardiopulmonary 
resuscitation, he died <12 hours after his second admission 
to the pediatric emergency ward.
An autopsy was performed with the prior consent of the 
parents. Pulmonary edema and multiple foci of polymorph 
inﬂ  ammatory inﬁ  ltrate were present in lung samples. En-
cephalitic necrotic lesions were multifocal but predominant 
in the inferior brainstem and superior cervical medulla. Re-
spiratory centers were affected, as were vegetative nucle-
ates of the medulla oblongata (Figure 1). No inﬂ  ammatory 
or necrotic areas were found in cardiac muscle.
An enterovirus was isolated in the MRC-5 cell culture 
from a bronchial aspirate taken just before death. An en-
terovirus was also isolated in an autopsy nasal swab. Other 
autopsy samples (lung, spleen, and urine) were positive for 
enterovirus by reverse transcription–PCR (RT-PCR) (En-
terovirus consensus kit, Argene, Verniolle, France), but no 
virus was isolated from these samples. Brain tissue could 
not be used for virologic studies because of formalin ﬁ  xa-
tion. The enterovirus strain isolated in cell culture was sent 
to the French National Reference Centre for Enteroviruses, 
where it was identiﬁ  ed as EV71 by partial viral protein 
(VP) 1 sequencing (7). A second analysis was performed 
that targeted the 891 nucleotides of the VP1 gene, as de-
scribed by Bible et al. (8). This sequence was compared by 
phylogenetic analysis with 34 GenBank-selected VP1 en-
terovirus 71 strains (Table). A phylogenetic tree was con-
structed by neighbor-joining, using the Kimura 2-parameter 
distance method to deﬁ  ne relationships between the cur-
rent isolate and other EV71 subgenogroups. The VP1 se-
quence of the French patient who died clustered with VP1 
sequences belonging to the C2 subgenogroup (Figure 2). 
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DOI: 10.3201/eid1511.090493The 2 closest-matching isolates originated from 2 young 
children admitted to the Brest Hospital emergency ward 
a few months later, in June and July 2008, respectively. 
The ﬁ  rst, 13 months of age, was admitted for acute respira-
tory syndrome, which rapidly resolved. Enterovirus 71 was 
isolated from the child’s bronchial secretions. The second 
child, 31 months of age, had acute gingivostomatitis, fever, 
and cerebellar syndrome evocative of meningoencephalitis. 
Enterovirus was isolated from buccal lesions, but no virus 
was detected by RT-PCR in cerebrospinal ﬂ  uid (CSF), even 
though pleocytosis was present. He recovered quickly. The 
VP1 full-length sequences of the 3 strains were deposited 
in GenBank under the accession nos. FJ824734–FJ824736. 
The high nucleotide identity among the 3 strains (>98%), 
and their place and period of circulation suggest a probable 
identical ancestral strain, which remains undeﬁ  ned. The 
origin of the EV71 strain responsible for the substantial 
pulmonary edema described here remains unknown. The 
3 strains isolated clustered with 3 other European strains, 
isolated in 2006 and 2008 in the United Kingdom (8,9), and 
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Figure 1. A) Horizontal section of the medulla at the level of the 
inferior olivari nuclei, showing multiple inﬂ  ammatory areas (clear 
areas); original magniﬁ  cation ×4. B) Severe edematous area with 
inﬂ  ammatory cells, macrophages, edema, and perivascular cufﬁ  ng 
(arrow); original magniﬁ  cation x200, hematoxylin-eosin stain.
Figure 2. Phylogenetic relationships between 3 French strains 
and 34 worldwide enterovirus 71 GenBank-selected strains based 
on alignment of complete viral protein (VP) 1 coding sequences. 
The prototype coxsackievirus A16 (CoxA16-G10) was used as 
the outgroup virus. The phylogenetic tree was constructed by the 
neighbor-joining method by using MEGA4 (www.megasoftware.
net). Bootstrap values (>70%) derived from 1,000 samplings are 
shown at the nodes of the tree. Phylogenetic separation of C2 
isolates appear in accordance with time and place of isolation. 
Isolates from this study are indicated by black squares (the strain 
isolated from the 17-month-old boy with fatal pulmonary edema 
is shown in boldface with **), and the other European circulating 
strains by black triangles. Branch lengths are drawn to scale. Scale 
bar indicates 5% of nucleotide sequence divergence.
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with 2 Asian strains, isolated in 2007 in Thailand and in 
2008 in Singapore and Thailand (GenBank, unpub. data).
Conclusions
Acute pulmonary edema in EV71 infections was rarely 
reported before the 1998 outbreak in Taiwan (12). Since 
then, this disease, which is often fatal, has been more fre-
quently described, with known prognostic factors, includ-
ing clinical and biologic features such as central nervous 
system involvement, leukocytosis, decreased blood pres-
sure, and hyperglycemia (13). The fatal infection reported 
here, which ran a biphasic course, featured all of these signs, 
with death occurring within a few hours of the onset of re-
spiratory distress. This devastating syndrome is believed to 
result from the extensive damage of bulbar vasomotor and 
respiratory centers (Figure 1). In the study by Kao et al. 
all 21 patients who had acute pulmonary edema associated 
with these signs died within 4 hours of the development of 
acute respiratory distress syndrome (13).
No reports of fatal cases of EV71 infection in Europe 
have been made since cases were reported in Hungary in 
1978 (9–11,14) with the exception of a fatal case of panen-
cephalitis associated with subgenogroup C2 in the United 
Kingdom (8). No single neurovirulent genotype appears to 
be associated with severe and fatal cases; at least 3 separate 
genotypes have been isolated from patients with fatal cases 
in Malaysia (Sarawak), Japan, and Taiwan (6). A similar 
subgenogroup such as C1 may be associated with compli-
cated disease in Sarawak and asymptomatic infection in 
Norway (2,10). A speciﬁ  c marker for virulence has yet to 
be deﬁ  ned.
Further studies are required to estimate the prevalence 
of EV71 infection, and only extensive clinical, virologic, 
and anatomopathologic investigation may determine the 
actual prevalence of EV71 in severe and sometimes fatal 
neurologic diseases. EV71, like poliovirus, is not always 
recovered from CSF during central nervous system infec-
tion (15). This fact underscores the importance of virologic 
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Table. EV71 clinical strains used in phylogenetic analysis of the complete VP1 gene* 
GenBank
accession no.  Year Origin Clinical  features  Isolate Genogroup  Reference
U22521 1970 USA Encephalitis BrCr-CA-70 A (1)
AF135883 1974 Australia Meningitis 2604-AUS-74 B1 (1)
AF135870 1977 USA NA 2231-NY-77 B1 (1)
AF009533 1987 USA Gastroenteritis 7631-PA-87  B2 (1)
AF009540 1988 USA Fever 2222-IA-88 B2 (1)
AF376117 1998 Singapore HFMD 3799/SIN/98 B3 (2)
AF376095 1999 Australia HFMD 18F/AUS/6/99 B3 (2)
AF376084 2000 Sarawak HFMD S21082/SAR/2000  B4 (2)
AF376111 2000 Singapore NA 2027/SIN/2001 B4 (2)
AF376121 2000 Singapore HFMD 5511/SIN/2000 B5 (2)
FM201341 2006 Brunei NA BRU/2006/35247 B5 (5)
AF376087 2000 Sarawak HFMD S40221/SAR/2000  C1 (2)
DQ452074 2003 Norway  NA 804/NO/2003 C1 (10)
AM939598 2005 UK Unspecified neurologic disease  HO-5400-288-05  C1 (8)
AF135950 1998 Missouri Meningitis 2814-MO-98 C2 (1)
AF136379 1998 Taiwan Death NCKU9822 C2 (3)
AM939583 1999 UK Aseptic meningitis  EP/5622/99 C2 (8)
AF376108 1999 Australia Meningitis 7F/AUS/6/99 C2 (2)
AF376102 1999 Australia HFMD 27M/AUS/2/99 C2 (2)
AF376110 1999 Australia Ataxia 9F/AUS/6/99 C2 (2)
AY208099  2001 France Guillain-Barré syndrome  W1244-50/2001  C2 (11)
AM939604 2006 UK Meningitis HO-6332-439-06 C2 (8)
AM939607 2006 UK Irritable, rash  HO-6364-255-06  C2 (8)
AM939597 2006 UK Panencephalitis, fatal  STH/MCN/06  C2 (8)
AM939599 2006 UK Difficulty walking  HO-6486-445-06  C2 (8)
FJ461786 2008 Singapore NA NUH0013/SIN/2008 C2 UD
FJ151492 2007 Thailand NA THA-07-01647 C2 UD
FJ525952 2008 Edinburgh NA CSF-2431/2008 C2 (9)
AY125966 2001 Korea NA KOR-EV71-01  C3 UD
AY125967 2002 Korea NA KOR-EV71-02  C3 UD
AF302996 1998 China NA SHZH98 C4 UD
AM490154 2005 Vietnam NA 707V/VNM/2005 C4 (4)
AM490163 2005 Vietnam NA 999T/VNM/2005 C5 (4)
AM490153 2005 Vietnam NA 666T/VNM/2005 C5 (4)
*EV, enterovirus; VP, viral protein; HFMD, hand, foot, and mouth disease; NA, not available; UD, unpublished data. investigations on peripheral samples (throat swabs, urine, 
stool, and vesicles).
Since 2006, centers participating in the French En-
terovirus Surveillance Network have declared a signiﬁ  -
cantly growing number of EV71 infections (D. Antona, 
pers. comm.). The international spread of EV71 outside 
the Asia-Paciﬁ  c region needs to be vigilantly monitored, 
because both the possibility of an outbreak and the unpre-
dictability of virus circulation patterns represent a public 
health concern.
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